Mitochondrial H2O2 as an enable signal for triggering autophosphorylation of insulin receptor in neurons

Journal of Molecular Signaling

Volumn 8, Issue , 2013, Pages

  Persiyantseva, Nadezhda A ^a   Storozhevykh, Tatiana P ^a   Senilova, Yana E ^a   Gorbacheva, Lubov R ^b   Pinelis, Vsevolod G ^a   Pomytkin, Igor A ^c  

^a Russian Academy of Medical Sciences   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c Biosignal Ltd   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DIPHENYLIODONIUM SALT; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INSULIN RECEPTOR; PEROXIREDOXIN; PERTUSSIS TOXIN; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; PROTEINASE INHIBITOR; RHODAMINE 123; SUCCINATE DEHYDROGENASE; UBIQUINOL CYTOCHROME C REDUCTASE; VANADATE SODIUM;

ADIPOCYTE; ANIMAL CELL; AREA UNDER THE CURVE; ARTICLE; AUTOPHOSPHORYLATION; BRAIN CELL CULTURE; CLINICAL DECISION MAKING; CONTROLLED STUDY; DENDRITIC SPINE; DOSE RESPONSE; ENZYME KINETICS; ENZYME LINKED IMMUNOSORBENT ASSAY; INSULIN RESISTANCE; MEMBRANE DEPOLARIZATION; MITOCHONDRION; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84884926885     PISSN: None     EISSN: 17502187     Source Type: Journal    
DOI: 10.1186/1750-2187-8-11     Document Type: Article

References (75)

1. White MF, Shoelson SE, Keutmann H, Kahn CR. A cascade of tyrosine autophosphorylation in the β-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 1988, 263:2969-2980.
2. Rosen OM, Herrera R, Olowe Y, Petruzzelli LM, Cobb MH. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc Natl Acad Sci USA 1983, 80:3237-3240. 10.1073/pnas.80.11.3237, 394015, 6574482.
3. Wie L, Hubbard SR, Hendrickson WA, Ellis L. Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine Kinase domain. J Biol Chem 1995, 270:8122-8130. 10.1074/jbc.270.14.8122, 7713916.
4. White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994, 269:1-4.
5. Mukherjee SP, Lane RH, Lynn WS. Endogenous hydrogen peroxide and peroxidative metabolism in adipocytes in response to insulin and sulfhydryl reagents. Biochem Pharmacol 1978, 27(22):2589-2594. 10.1016/0006-2952(78)90332-5, 728211.
6. May JM, de Haen C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J Biol Chem 1979, 254(7):2214-2220.
7. Goldstein BJ, Mahadev K, Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005, 54:311-321. 10.2337/diabetes.54.2.311, 1464057, 15677487.
8. Mahadev K, Zilbering A, Zhu L, Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 2001, 276:21938-21942. 10.1074/jbc.C100109200, 11297536.
9. Pomytkin IA, Kolesova OE. Key role of succinate dehydrogenase in insulin-induced inactivation of protein tyrosine phosphatases. Bull Exp Biol Med 2002, 133:568-570. 10.1023/A:1020229724717, 12447467.
10. Schmid E, El Benna J, Galter D, Klein G, Dröge W. Redox priming of the insulin receptor beta-chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation. FASEB J 1998, 12(10):863-870.
11. Schmid E, Hotz-Wagenblatt A, Hacj V, Dröge W. Phosphorylation of the insulin receptor kinase by phosphocreatine in combination with hydrogen peroxide: the structural basis of redox priming. FASEB J 1999, 13(12):1491-1500.
12. Abbott MA, Wells DG, Fallon JR. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci 1999, 19:7300-7308.
13. Chiu SL, Cline HT. Insulin receptor signaling in the development of neuronal structure and function. Neural Dev 2010, 5:7. 10.1186/1749-8104-5-7, 2843688, 20230616.
14. Duarte AI, Moreira PI, Oliveira CR. Insulin in central nervous system: more than just a peripheral hormone. J Aging Res 2012, 2012:384017. 3303591, 22500228.
15. Gammeltoft S, Fehlmann M, Van Obberghen E. Insulin receptors in the mammalian central nervous system: binding characteristics and subunit structure. Biochimie 1985, 67(10-11):1147-1153.
16. Yamaguchi Y, Flier JS, Yokota A, Benecke H, Backer JM, Moller DE. Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 1991, 129(4):2058-2066. 10.1210/endo-129-4-2058, 1655392.
17. Storozhevykh TP, Senilova YE, Persiyantseva NA, Pinelis VG, Pomytkin IA. Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. BMC Neurosci 2007, 8:84. 10.1186/1471-2202-8-84, 2089077, 17919343.
18. Antunes F, Cadenas E. Estimation of H2O2 gradients across biomembranes. FEBS Lett 2000, 475:121-126. 10.1016/S0014-5793(00)01638-0, 10858501.
19. Goldbeter A, Koshland DE. An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci USA 1981, 78(11):6840-6844. 10.1073/pnas.78.11.6840, 349147, 6947258.
20. Ferrell JE. Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs. Trends Biochem Sci 1996, 21:460-466. 10.1016/S0968-0004(96)20026-X, 9009826.
21. Pardee AB, Potter VR. Inhibition of succinic dehydrogenase by oxalacetate. J Biol Chem 1948, 176:1085-1094.
22. Nulton-Persson AC, Szweda LI. Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem 2001, 276:23357-23361. 10.1074/jbc.M100320200, 11283020.
23. Moser MD, Matsuzaki S, Humphries KM. Inhibition of succinate-linked respiration and complex II activity by hydrogen peroxide. Arch Biochem Biophys 2009, 488:69-75. 10.1016/j.abb.2009.06.009, 19540189.
24. Tretter L, Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci 2000, 20:8972-8979.
25. Ackrell BA, Kearney EB, Edmondson D. Mechanism of the reductive activation of succinate dehydrogenase. J Biol Chem 1975, 250:7114-7119.
26. Gutman M, Kearney EB, Singer TP. Control of succinate dehydrogenase in mitochondria. Biochemistry 1971, 10:4763-4770. 10.1021/bi00801a025, 5140191.
27. Gutman M, Kearney EB, Singer TP. Multiple control mechanisms for succinate dehydrogenase in mitochondria. Biochem Biophys Res Commun 1971, 44:526-532. 10.1016/S0006-291X(71)80114-6, 5123196.
28. Gutman M, Kearney EB, Singer TP. Activation of succinate dehydrogenase by electron flux from NADH and its possible regulatory function. Biochem Biophys Res Commun 1971, 42:1016-1023. 10.1016/0006-291X(71)90005-2, 4323843.
29. de Gómez-Puyou MT, Chávez E, Freites D, Gómez-Puyou A. On the regulation of succinate dehydrogenase in brain mitochondria. FEBS Lett 1972, 22:57-60. 10.1016/0014-5793(72)80218-7, 11946560.
30. Singer TP, Gutman M, Kearney EB. On the need for regulation of succinate dehydrogenase. FEBS Lett 1971, 17:11-13. 10.1016/0014-5793(71)80550-1, 11945983.
31. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973, 134:707-716. 1177867, 4749271.
32. Votyakova TV, Reynolds IJ. DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondria. J Neurochem 2001, 79:266-277.
33. Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 2002, 80:780-787. 10.1046/j.0022-3042.2002.00744.x, 11948241.
34. Gyulkhandanyan AV, Pennefather PS. Shift in the localization of sites of hydrogen peroxide production in brain mitochondria by mitochondrial stress. J Neurochem 2004, 90:405-421. 10.1111/j.1471-4159.2004.02489.x, 15228597.
35. Kudin AP, Bimpong-Buta NY, Vielhaber S, Elger CE, Kunz WS. Characterization of superoxide-producing sites in isolated brain mitochondria. J Biol Chem 2004, 279:4127-4135.
36. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009, 417:1-13. 10.1042/BJ20081386, 2605959, 19061483.
37. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995, 64:97-112. 10.1146/annurev.bi.64.070195.000525, 7574505.
38. Quinlan CL, Orr AL, Perevoshchikova IV, Treberg JR, Ackrell BA, Brand MD. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J Biol Chem 2012, 287:27255-27264. 10.1074/jbc.M112.374629, 3411067, 22689576.
39. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 1997, 416:15-18. 10.1016/S0014-5793(97)01159-9, 9369223.
40. Toescu EC, Verkhratsky A. Assessment of mitochondrial polarization status in living cells based on analysis of the spatial heterogeneity of rhodamine 123 fluorescence staining. Pflugers Arch 2000, 440:941-947. 10.1007/s004240000390, 11041562.
41. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, Goldstein BJ. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 2001, 276(52):48662-48669. 10.1074/jbc.M105061200, 11598110.
42. Mahadev K, Wu X, Motoshima H, Goldstein BJ. Integration of multiple downstream signals determines the net effect of insulin on MAP kinase vs. PI 3′-kinase activation: potential role of insulin-stimulated H(2)O(2). Cell Signal 2004, 16(3):323-331. 10.1016/j.cellsig.2003.08.002, 14687662.
43. Biswas S, Gupta MK, Chattopadhyay D, Mukhopadhyay CK. Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase. Am J Physiol Heart Circ Physiol 2007, 292(2):H758-H766.
44. Aldieri E, Riganti C, Polimeni M, Gazzano E, Lussiana C, Campia I, Ghigo D. Classical inhibitors of NOX NAD(P)H oxidases are not specific. Curr Drug Metab 2008, 9(8):686-696. 10.2174/138920008786049285, 18855607.
45. Majander A, Finel M, Wikstrom M. Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I). J Biol Chem 1994, 269(33):21037-21042.
46. Li Y, Trush MA. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 1998, 253(2):295-299. 10.1006/bbrc.1998.9729, 9878531.
47. Mahadev K, Motoshima H, Wu X, Ruddy JM, Arnold RS, Cheng G, Lambeth JD, Goldstein BJ. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol 2004, 24:1844-1854. 10.1128/MCB.24.5.1844-1854.2004, 350558, 14966267.
48. Krieger-Brauer HI, Medda PK, Kather H. Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Galphai2. J Biol Chem 1997, 272:10135-10143. 10.1074/jbc.272.15.10135, 9092559.
49. Moxham CM, Malbon CC. Insulin action impaired by deficiency of the G-protein subunit G ialpha2. Nature 1996, 379(6568):840-844. 10.1038/379840a0, 8587610.
50. Chen JF, Guo JH, Moxham CM, Wang HY, Malbon CC. Conditional, tissue-specific expression of Q205L G alpha i2 in vivo mimics insulin action. J Mol Med (Berl) 1997, 75(4):283-289. 10.1007/s001090050113, 9151214.
51. Song X, Zheng X, Malbon CC, Wang H. Galpha i2 enhances in vivo activation of and insulin signaling to GLUT4. J Biol Chem 2001, 276(37):34651-34658. 10.1074/jbc.M105894200, 11457861.
52. Tao J, Malbon CC, Wang HY. Galpha(i2) enhances insulin signaling via suppression of protein-tyrosine phosphatase 1B. J Biol Chem 2001, 276(43):39705-39712. 10.1074/jbc.M105216200, 11500506.
53. Kreuzer J, Nurnberg B, Krieger-Brauer HI. Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins. Biochem J 2004, 380(Pt 3):831-836. 1224225, 15025562.
54. Khan ZU, Gutierrez A. Distribution of C-terminal splice variant of G alpha i2 in rat and monkey brain. Neuroscience 2004, 127(4):833-843. 10.1016/j.neuroscience.2004.05.017, 15312896.
55. Montmayeur JP, Borrelli E. Targeting of G alpha i2 to the Golgi by alternative spliced carboxyl-terminal region. Science 1994, 263(5143):95-98. 10.1126/science.8272874, 8272874.
56. Wedegaertner PB. Characterization of subcellular localization and stability of a splice variant of G alpha i2. BMC Cell Bio. 2002, 3:12.
57. Clarke DW, Mudd L, Boyd FT, Fields M, Raizada MK. Insulin is released from rat brain neuronal cells in culture. J Neurochem 1986, 47:831-836.
58. Wei LT, Matsumoto H, Rhoads DE. Release of immunoreactive insulin from rat brain synaptosomes under depolarizing conditions. J Neurochem 1990, 54:1661-1665. 10.1111/j.1471-4159.1990.tb01219.x, 2182775.
59. Li Z, Okamoto K, Hayashi Y, Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887. 10.1016/j.cell.2004.11.003, 15607982.
60. Flohé L, Loschen G, Günzler WA, Eichele E. Glutathione peroxidase, V. The kinetic mechanism. Hoppe Seylers Z Physiol Chem 1972, 353:987-999. 10.1515/bchm2.1972.353.1.987, 5066111.
61. Peskin AV, Low FM, Paton LN, Maghzal GJ, Hampton MB, Winterbourn CC. The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents. J Biol Chem 2007, 282:11885-11892.
62. Cox AG, Winterbourn CC, Hampton MB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 2009, 425:313-325.
63. McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, Lei XG. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci USA 2004, 101:8852-8857. 10.1073/pnas.0308096101, 428436, 15184668.
64. Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, Stepto N, Wu B, Mitchell CA, Tonks NK, Watt MJ, Febbraio MA, Crack PJ, Andrikopoulos S, Tiganis T. Reactive oxygen species enhance insulin sensitivity. Cell Metab 2009, 10:260-272. 10.1016/j.cmet.2009.08.009, 2892288, 19808019.
65. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012, 122:1316-1338. 10.1172/JCI59903, 3314463, 22476197.
66. Aksenov MY, Tucker HM, Nair P, Aksenova MV, Butterfield DA, Estus S, Markesbery WR. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J Mol Neurosci 1998, 11:151-164. 10.1385/JMN:11:2:151, 10096042.
67. Aksenov MY, Markesbery WR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 2001, 302:141-145. 10.1016/S0304-3940(01)01636-6, 11290407.
68. Kim SH, Fountoulakis M, Cairns N, Lubec G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 2001, 61:223-235.
69. Cumming RC, Dargusch R, Fischer WH, Schubert D. Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells. J Biol Chem 2007, 282:30523-30534. 10.1074/jbc.M700869200, 17761673.
70. Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 2003, 967:152-160. 10.1016/S0006-8993(02)04243-9, 12650976.
71. Sultana R, Boyd-Kimball D, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA. Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis 2007, 11:153-164.
72. Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G. Oxidative stress signalling in Alzheimer's disease. Brain Res 2004, 1000:32-39. 10.1016/j.brainres.2004.01.012, 15053949.
73. Moreira PI, Zhu X, Liu Q, Honda K, Siedlak SL, Harris PL, Smith MA, Perry G. Compensatory responses induced by oxidative stress in Alzheimer disease. Biol Res 2006, 39:7-13.
74. Andreeva N, Khodorov B, Stelmashook E, Cragoe E, Victorov I. Inhibition of Na+/Ca2+ exchange enhances delayed neuronal death elicited by glutamate in cerebellar granule cell cultures. Brain Res 1991, 548:322-325. 10.1016/0006-8993(91)91141-M, 1678303.
75. Khodorov B, Pinelis V, Vergun O, Storozhevykh T, Vinskaya N. Mitochondrial deenergization underlies neuronal calcium overload following a prolonged glutamate challenge. FEBS Lett 1996, 397:230-234. 10.1016/S0014-5793(96)01139-8, 8955353.